Abstract
In this review, we summarize our current understanding of the pathophysiology of fragility fractures that occur for the first time during pregnancy and lactation, and provide guidance on appropriate investigations and treatment strategies. Most affected women will have had no prior bone density reading, and so the extent of bone loss that may have occurred during pregnancy or lactation is uncertain. During pregnancy, intestinal calcium absorption doubles in order to meet the fetal demand for calcium, but if maternal intake of calcium is insufficient to meet the combined needs of the mother and baby, the maternal skeleton will undergo resorption during the third trimester. During lactation, several hormonal changes, independent of maternal calcium intake, program a 5–10 % loss of trabecular mineral content in order to provide calcium to milk. After weaning the baby, the maternal skeleton is normally restored to its prior mineral content and strength. This physiological bone resorption during reproduction does not normally cause fractures; instead, women who do fracture are more likely to have additional secondary causes of bone loss and fragility. Transient osteoporosis of the hip may affect one or both femoral heads during pregnancy but it involves localized edema and not skeletal resorption. Case reports have described the use of calcitonin, bisphosphonates, strontium ranelate, teriparatide, vertebroplasty, and kyphoplasty to treat post-partum vertebral fractures. However, the need for such treatments is uncertain given that a progressive increase in bone mass subsequently occurs in most women who present with a fracture during pregnancy or lactation.
This is a preview of subscription content, access via your institution.



References
Givens MH, Macy IC (1933) The chemical composition of the human fetus. J Biol Chem 102:7–17
Comar CL (1956) Radiocalcium studies in pregnancy. Ann N Y Acad Sci 64:281–298
Kovacs CS (2014) Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones. Physiol Rev 94(4):1143–1218. doi:10.1152/physrev.00014.2014
Kovacs CS, Kronenberg HM (1997) Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 18(6):832–872. doi:10.1210/edrv.18.6.0319
Kovacs CS (2011) Calcium and bone metabolism disorders during pregnancy and lactation. Endocrinol Metab Clin North Am 40(4):795–826. doi:10.1016/j.ecl.2011.08.002
Heaney RP, Skillman TG (1971) Calcium metabolism in normal human pregnancy. J Clin Endocrinol Metab 33(4):661–670. doi:10.1210/jcem-33-4-661
Kovacs CS (2014) The role of PTHrP in regulating mineral metabolism during pregnancy, lactation, and fetal/neonatal development. Clin Rev Bone Mineral Metabol 12(3):142–164. doi:10.1007/s12018-014-9157-6
Wasserman RH, Comar CL, Nold MM, Lengemann FW (1957) Placental transfer of calcium and strontium in the rat and rabbit. Am J Physiol 189(1):91–97
Kovacs CS (2012) The role of vitamin D in pregnancy and lactation: insights from animal models and clinical studies. Ann Rev Nutr 32:9.1–9.27. doi:10.1146/annurev-nutr-071811-150742
Bikle DD, Gee E, Halloran B, Haddad JG (1984) Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest 74(6):1966–1971. doi:10.1172/JCI111617
Halloran BP, DeLuca HF (1980) Calcium transport in small intestine during pregnancy and lactation. Am J Physiol 239:E64–E68
Brommage R, Baxter DC, Gierke LW (1990) Vitamin D-independent intestinal calcium and phosphorus absorption during reproduction. Am J Physiol 259:G631–G638
Fudge NJ, Kovacs CS (2010) Pregnancy up-regulates intestinal calcium absorption and skeletal mineralization independently of the vitamin D receptor. Endocrinology 151(3):886–895. doi:10.1210/en.2009-1010
Halloran BP, DeLuca HF (1980) Skeletal changes during pregnancy and lactation: the role of vitamin D. Endocrinology 107:1923–1929
Purdie DW, Aaron JE, Selby PL (1988) Bone histology and mineral homeostasis in human pregnancy. Br J Obstet Gynaecol 95(9):849–854
Moller UK, Við Streym S, Mosekilde L, Rejnmark L (2012) Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study. Osteoporos Int 23(4):1213–1223. doi:10.1007/s00198-011-1654-6
To WW, Wong MW (2011) Changes in bone mineral density of the os calcis as measured by quantitative ultrasound during pregnancy and 24 months after delivery. Aust N Z J Obstet Gynaecol 51(2):166–171. doi:10.1111/j.1479-828X.2010.01266.x
Khosla S, van Heerden JA, Gharib H, Jackson IT, Danks J, Hayman JA, Martin TJ (1990) Parathyroid hormone-related protein and hypercalcemia secondary to massive mammary hyperplasia. N Engl J Med 322(16):1157. doi:10.1056/NEJM199004193221613
Jackson IT, Saleh J, van Heerden JA (1989) Gigantic mammary hyperplasia in pregnancy associated with pseudohyperparathyroidism. Plast Reconstr Surg 84(5):806–810
Eller-Vainicher C, Ossola MW, Beck-Peccoz P, Chiodini I (2012) PTHrP-associated hypercalcemia of pregnancy resolved after delivery: a case report. Eur J Endocrinol 166(4):753–756. doi:10.1530/eje-11-1050
Trotter M, Hixon BB (1974) Sequential changes in weight, density, and percentage ash weight of human skeletons from an early fetal period through old age. Anat Rec 179(1):1–18. doi:10.1002/ar.1091790102
Kovacs CS (2005) Calcium and bone metabolism during pregnancy and lactation. J Mammary Gland Biol Neoplasia 10(2):105–118. doi:10.1007/s10911-005-5394-0
Wysolmerski JJ (2010) Interactions between breast, bone, and brain regulate mineral and skeletal metabolism during lactation. Ann N Y Acad Sci 1192:161–169. doi:10.1111/j.1749-6632.2009.05249.x
Yamamoto M, Duong LT, Fisher JE, Thiede MA, Caulfield MP, Rosenblatt M (1991) Suckling-mediated increases in urinary phosphate and 3′,5′-cyclic adenosine monophosphate excretion in lactating rats: possible systemic effects of parathyroid hormone-related protein. Endocrinology 129(5):2614–2622. doi:10.1210/endo-129-5-2614
Dobnig H, Kainer F, Stepan V, Winter R, Lipp R, Schaffer M, Kahr A, Nocnik S, Patterer G, Leb G (1995) Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism. J Clin Endocrinol Metab 80(12):3699–3707. doi:10.1210/jcem.80.12.8530622
Thiede MA (1989) The mRNA encoding a parathyroid hormone-like peptide is produced in mammary tissue in response to elevations in serum prolactin. Mol Endocrinol 3(9):1443–1447
Ratcliffe WA, Thompson GE, Care AD, Peaker M (1992) Production of parathyroid hormone-related protein by the mammary gland of the goat. J Endocrinol 133:87–93
Stiegler C, Leb G, Kleinert R, Warnkross H, Ramschak-Schwarzer S, Lipp R, Clarici G, Krejs GJ, Dobnig H (1995) Plasma levels of parathyroid hormone-related peptide are elevated in hyperprolactinemia and correlated to bone density status. J Bone Miner Res 10(5):751–759. doi:10.1002/jbmr.5650100512
Kovacs CS, Chik CL (1995) Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH-related peptide levels. J Clin Endocrinol Metab 80(10):3036–3042. doi:10.1210/jcem.80.10.7559893
Rabbani SA, Khalili P, Arakelian A, Pizzi H, Chen G, Goltzman D (2005) Regulation of parathyroid hormone-related peptide by estradiol: effect on tumor growth and metastasis in vitro and in vivo. Endocrinology 146(7):2885–2894. doi:10.1210/en.2005-0062
VanHouten J, Dann P, McGeoch G, Brown EM, Krapcho K, Neville M, Wysolmerski JJ (2004) The calcium-sensing receptor regulates mammary gland parathyroid hormone-related protein production and calcium transport. J Clin Invest 113(4):598–608. doi:10.1172/JCI18776
Ardeshirpour L, Dann P, Pollak M, Wysolmerski J, VanHouten J (2006) The calcium-sensing receptor regulates PTHrP production and calcium transport in the lactating mammary gland. Bone 38(6):787–793. doi:10.1016/j.bone.2005.11.009
Bucht E, Telenius-Berg M, Lundell G, Sjoberg HE (1986) Immunoextracted calcitonin in milk and plasma from totally thyroidectomized women. evidence of monomeric calcitonin in plasma during pregnancy and lactation. Acta Endocrinol (Copenh) 113:529–535
Woodrow JP, Sharpe CJ, Fudge NJ, Hoff AO, Gagel RF, Kovacs CS (2006) Calcitonin plays a critical role in regulating skeletal mineral metabolism during lactation. Endocrinology 147(9):4010–4021. doi:10.1210/en.2005-1616
Woodrow JP (2009) Calcitonin modulates skeletal mineral loss during lactation through interactions in mammary tissue and directly though osteoclasts in bone [PhD thesis]. PhD, Memorial University of Newfoundland, St. John’s, Newfoundland
Ren Y, Chien J, Sun YP, Shah GV (2001) Calcitonin is expressed in gonadotropes of the anterior pituitary gland: its possible role in paracrine regulation of lactotrope function. J Endocrinol 171(2):217–228
Yuan R, Kulkarni T, Wei F, Shah GV (2005) Targeted overexpression of calcitonin in gonadotrophs of transgenic mice leads to chronic hypoprolactinemia. Mol Cell Endocrinol 229(1–2):193–203
Tohei A, VandeGarde B, Arbogast LA, Voogt JL (2000) Calcitonin inhibition of prolactin secretion in lactating rats: mechanism of action. Neuroendocrinology 71(5):327–332
Colaianni G, Di Benedetto A, Zhu LL, Tamma R, Li J, Greco G, Peng Y, Dell’Endice S, Zhu G, Cuscito C, Grano M, Colucci S, Iqbal J, Yuen T, Sun L, Zaidi M, Zallone A (2011) Regulated production of the pituitary hormone oxytocin from murine and human osteoblasts. Biochem Biophys Res Commun 411(3):512–515. doi:10.1016/j.bbrc.2011.06.158
Colaianni G, Sun L, Di Benedetto A, Tamma R, Zhu LL, Cao J, Grano M, Yuen T, Colucci S, Cuscito C, Mancini L, Li J, Nishimori K, Bab I, Lee HJ, Iqbal J, Young WS 3rd, Rosen C, Zallone A, Zaidi M (2012) Bone marrow oxytocin mediates the anabolic action of estrogen on the skeleton. J Biol Chem 287(34):29159–29167. doi:10.1074/jbc.M112.365049
Hernandez LL, Gregerson KA, Horseman ND (2012) Mammary gland serotonin regulates parathyroid hormone-related protein and other bone-related signals. Am J Physiol Endocrinol Metab 302(8):E1009–E1015. doi:10.1152/ajpendo.00666.2011
Horseman ND, Hernandez LL (2014) New concepts of breast cell communication to bone. Trends Endocrinol Metab 25(1):34–41. doi:10.1016/j.tem.2013.08.004
VanHouten JN, Dann P, Stewart AF, Watson CJ, Pollak M, Karaplis AC, Wysolmerski JJ (2003) Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation. J Clin Invest 112(9):1429–1436. doi:10.1172/JCI19504
Ardeshirpour L, Brian S, Dann P, VanHouten J, Wysolmerski J (2010) Increased PTHrP and decreased estrogens alter bone turnover but do not reproduce the full effects of lactation on the skeleton. Endocrinology 151(12):5591–5601. doi:10.1210/en.2010-0566
VanHouten JN, Wysolmerski JJ (2003) Low estrogen and high parathyroid hormone-related peptide levels contribute to accelerated bone resorption and bone loss in lactating mice. Endocrinology 144(12):5521–5529. doi:10.1210/en.2003-0892
Kirby BJ, Ardeshirpour L, Woodrow JP, Wysolmerski JJ, Sims NA, Karaplis AC, Kovacs CS (2011) Skeletal recovery after weaning does not require PTHrP. J Bone Miner Res 26(6):1242–1251. doi:10.1002/jbmr.339
Kirby BJ, Ma Y, Martin HM, Buckle Favaro KL, Karaplis AC, Kovacs CS (2013) Upregulation of calcitriol during pregnancy and skeletal recovery after lactation do not require parathyroid hormone. J Bone Miner Res 28(9):1987–2000. doi:10.1002/jbmr.1925
Brommage R, DeLuca HF (1985) Regulation of bone mineral loss during lactation. Am J Physiol 248(2 Pt 1):E182–E187
Teti A, Zallone A (2009) Do osteocytes contribute to bone mineral homeostasis? osteocytic osteolysis revisited. Bone 44(1):11–16. doi:10.1016/j.bone.2008.09.017
Qing H, Ardeshirpour L, Pajevic PD, Dusevich V, Jahn K, Kato S, Wysolmerski J, Bonewald LF (2012) Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation. J Bone Miner Res 27(5):1018–1029. doi:10.1002/jbmr.1567
Sowers M (1996) Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis. J Bone Miner Res 11(8):1052–1060. doi:10.1002/jbmr.5650110803
Chan GM, Slater P, Ronald N, Roberts CC, Thomas MR, Folland D, Jackson R (1982) Bone mineral status of lactating mothers of different ages. Am J Obstet Gynecol 144(4):438–441
Chan GM, McMurry M, Westover K, Engelbert-Fenton K, Thomas MR (1987) Effects of increased dietary calcium intake upon the calcium and bone mineral status of lactating adolescent and adult women. Am J Clin Nutr 46(2):319–323
Sowers MF, Hollis BW, Shapiro B, Randolph J, Janney CA, Zhang D, Schork A, Crutchfield M, Stanczyk F, Russell-Aulet M (1996) Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA 276(7):549–554
Shomali ME, Ross DS (1999) Hypercalcemia in a woman with hypoparathyroidism associated with increased parathyroid hormone-related protein during lactation. Endocr Pract 5(4):198–200. doi:10.4158/EP.5.4.198
Caplan RH, Beguin EA (1990) Hypercalcemia in a calcitriol-treated hypoparathyroid woman during lactation. Obstet Gynecol 76(3 Pt 2):485–489
Cross NA, Hillman LS, Allen SH, Krause GF (1995) Changes in bone mineral density and markers of bone remodeling during lactation and postweaning in women consuming high amounts of calcium. J Bone Miner Res 10(9):1312–1320. doi:10.1002/jbmr.5650100907
Kalkwarf HJ, Specker BL, Bianchi DC, Ranz J, Ho M (1997) The effect of calcium supplementation on bone density during lactation and after weaning. N Engl J Med 337(8):523–528. doi:10.1056/NEJM199708213370803
Kolthoff N, Eiken P, Kristensen B, Nielsen SP (1998) Bone mineral changes during pregnancy and lactation: a longitudinal cohort study. Clin Sci (Lond) 94(4):405–412
Polatti F, Capuzzo E, Viazzo F, Colleoni R, Klersy C (1999) Bone mineral changes during and after lactation. Obstet Gynecol 94(1):52–56
Prentice A (2000) Calcium in pregnancy and lactation. Annu Rev Nutr 20:249–272. doi:10.1146/annurev.nutr.20.1.249
Prentice A, Jarjou LM, Cole TJ, Stirling DM, Dibba B, Fairweather-Tait S (1995) Calcium requirements of lactating Gambian mothers: effects of a calcium supplement on breast-milk calcium concentration, maternal bone mineral content, and urinary calcium excretion. Am J Clin Nutr 62(1):58–67
Prentice A, Jarjou LM, Stirling DM, Buffenstein R, Fairweather-Tait S (1998) Biochemical markers of calcium and bone metabolism during 18 months of lactation in Gambian women accustomed to a low calcium intake and in those consuming a calcium supplement. J Clin Endocrinol Metab 83(4):1059–1066. doi:10.1210/jcem.83.4.4737
Prentice A, Yan L, Jarjou LM, Dibba B, Laskey MA, Stirling DM, Fairweather-Tait S (1997) Vitamin D status does not influence the breast-milk calcium concentration of lactating mothers accustomed to a low calcium intake. Acta Paediatr 86(9):1006–1008
Laskey MA, Prentice A, Hanratty LA, Jarjou LM, Dibba B, Beavan SR, Cole TJ (1998) Bone changes after 3 mo of lactation: influence of calcium intake, breast-milk output, and vitamin n-receptor genotype. Am J Clin Nutr 67(4):685–692
Sowers M, Randolph J, Shapiro B, Jannausch M (1995) A prospective study of bone density and pregnancy after an extended period of lactation with bone loss. Obstet Gynecol 85(2):285–289. doi:10.1016/0029-7844(94)00351-D
Henderson PH 3rd, Sowers M, Kutzko KE, Jannausch ML (2000) Bone mineral density in grand multiparous women with extended lactation. Am J Obstet Gynecol 182(6):1371–1377. doi:10.1067/mob.2000.107468
Sowers M, Corton G, Shapiro B, Jannausch ML, Crutchfield M, Smith ML, Randolph JF, Hollis B (1993) Changes in bone density with lactation. JAMA 269(24):3130–3135
Miller SC, Bowman BM (2007) Rapid inactivation and apoptosis of osteoclasts in the maternal skeleton during the bone remodeling reversal at the end of lactation. Anat Rec (Hoboken) 290(1):65–73. doi:10.1002/ar.20403
Ardeshirpour L, Dann P, Adams DJ, Nelson T, VanHouten J, Horowitz MC, Wysolmerski JJ (2007) Weaning triggers a decrease in receptor activator of nuclear factor-kappaB ligand expression, widespread osteoclast apoptosis, and rapid recovery of bone mass after lactation in mice. Endocrinology 148(8):3875–3886. doi:10.1210/en.2006-1467
Collins JN, Kirby BJ, Woodrow JP, Gagel RF, Rosen CJ, Sims NA, Kovacs CS (2013) Lactating Ctcgrp nulls lose twice the normal bone mineral content due to fewer osteoblasts and more osteoclasts, whereas bone mass is fully restored after weaning in association with up-regulation of Wnt signaling and other novel genes. Endocrinology 154(4):1400–1413. doi:10.1210/en.2012-1931
Qing H, Bonewald LF (2009) Osteocyte remodeling of the perilacunar and pericanalicular matrix. Int J Oral Sci 1(2):59–65. doi:10.4248/ijos.09019
Liu XS, Ardeshirpour L, VanHouten JN, Shane E, Wysolmerski JJ (2012) Site-specific changes in bone microarchitecture, mineralization, and stiffness during lactation and after weaning in mice. J Bone Miner Res 27(4):865–875. doi:10.1002/jbmr.1503
Bowman BM, Miller SC (2001) Skeletal adaptations during mammalian reproduction. J Musculoskelet Neuronal Inter 1(4):347–355
Vajda EG, Bowman BM, Miller SC (2001) Cancellous and cortical bone mechanical properties and tissue dynamics during pregnancy, lactation, and postlactation in the rat. Biol Reprod 65(3):689–695
Bjørnerem A, Ghasem-Zadeh A, Vu T, Seeman E (2010) Bone microstructure during and after lactation [abstract]. J Bone Miner Res 25(Suppl 1):S121
Specker B, Binkley T (2005) High parity is associated with increased bone size and strength. Osteoporos Int 16(12):1969–1974. doi:10.1007/s00198-005-1978-1
Wiklund PK, Xu L, Wang Q, Mikkola T, Lyytikainen A, Volgyi E, Munukka E, Cheng SM, Alen M, Keinanen-Kiukaanniemi S, Cheng S (2012) Lactation is associated with greater maternal bone size and bone strength later in life. Osteoporos Int 23(7):1939–1945. doi:10.1007/s00198-011-1790-z
Cross NA, Hillman LS, Allen SH, Krause GF, Vieira NE (1995) Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal study. Am J Clin Nutr 61(3):514–523
Specker BL, Tsang RC, Ho ML (1991) Changes in calcium homeostasis over the first year postpartum: effect of lactation and weaning. Obstet Gynecol 78(1):56–62
Moller UK, Streym S, Mosekilde L, Heickendorff L, Flyvbjerg A, Frystyk J, Jensen LT, Rejnmark L (2013) Changes in calcitropic hormones, bone markers and insulin-like growth factor I (IGF-I) during pregnancy and postpartum: a controlled cohort study. Osteoporos Int 24(4):1307–1320. doi:10.1007/s00198-012-2062-2
Kalkwarf HJ, Specker BL, Heubi JE, Vieira NE, Yergey AL (1996) Intestinal calcium absorption of women during lactation and after weaning. Am J Clin Nutr 63(4):526–531
Kreiger N, Kelsey JL, Holford TR, O’Connor T (1982) An epidemiologic study of hip fracture in postmenopausal women. Am J Epidemiol 116(1):141–148
Aloia JF, Vaswani AN, Yeh JK, Ross P, Ellis K, Cohn SH (1983) Determinants of bone mass in postmenopausal women. Arch Intern Med 143(9):1700–1704
Aloia JF, Cohn SH, Vaswani A, Yeh JK, Yuen K, Ellis K (1985) Risk factors for postmenopausal osteoporosis. Am J Med 78(1):95–100
Hreshchyshyn MM, Hopkins A, Zylstra S, Anbar M (1988) Associations of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities. Am J Obstet Gynecol 159(2):318–322
Dequeker J, Tobing L, Rutten V, Geusens P (1991) Relative risk factors for osteoporotic fracture: a pilot study of the MEDOS questionnaire. Clin Rheumatol 10(1):49–53
Feldblum PJ, Zhang J, Rich LE, Fortney JA, Talmage RV (1992) Lactation history and bone mineral density among perimenopausal women. Epidemiology 3(6):527–531
Cumming RG, Klineberg RJ (1993) Breastfeeding and other reproductive factors and the risk of hip fractures in elderly women. Int J Epidemiol 22(4):684–691
Berning B, van Kuijk C, Schutte HE, Kuiper JW, Drogendijk AC, Fauser BC (1993) Determinants of lumbar bone mineral density in normal weight, non-smoking women soon after menopause. A study using clinical data and quantitative computed tomography. Bone Miner 21(2):129–139
Cure CC, Ramirez PC, Lopez-Jaramillo P (1998) Osteoporosis, pregnancy, and lactation. Lancet 352(9135):1227–1228
Cure-Cure C, Cure-Ramirez P, Teran E, Lopez-Jaramillo P (2002) Bone-mass peak in multiparity and reduced risk of bone-fractures in menopause. Int J Gynaecol Obstet 76(3):285–291
Bjornerem A, Ahmed LA, Jorgensen L, Stormer J, Joakimsen RM (2011) Breastfeeding protects against hip fracture in postmenopausal women: the Tromso study. J Bone Miner Res 26(12):2843–2850. doi:10.1002/jbmr.496
Chapman DJ (2012) Longer cumulative breastfeeding duration associated with improved bone strength. J Hum Lact 28(1):18–19. doi:10.1177/0890334411433573
Canal-Macias ML, Roncero-Martin R, Moran JM, Lavado-Garcia JM, Costa-Fernandez Mdel C, Pedrera-Zamorano JD (2013) Increased bone mineral density is associated with breastfeeding history in premenopausal Spanish women. Arch Med Sci : AMS 9(4):703–708. doi:10.5114/aoms.2013.36903
Heidari B, Heidari P, Nourooddini HG, Hajian-Tilaki KO (2013) Relationship between parity and bone mass in postmenopausal women according to number of parities and age. J Reprod Med 58(9–10):389–394
Schnatz PF, Marakovits KA, O’Sullivan DM (2010) Assessment of postmenopausal women and significant risk factors for osteoporosis. Obstet Gynecol Surv 65(9):591–596. doi:10.1097/OGX.0b013e3181fc6d30
Schnatz PF, Barker KG, Marakovits KA, O’Sullivan DM (2010) Effects of age at first pregnancy and breast-feeding on the development of postmenopausal osteoporosis. Menopause 17(6):1161–1166. doi:10.1097/gme.0b013e3181e0efb3
Paton LM, Alexander JL, Nowson CA, Margerison C, Frame MG, Kaymakci B, Wark JD (2003) Pregnancy and lactation have no long-term deleterious effect on measures of bone mineral in healthy women: a twin study. Am J Clin Nutr 77(3):707–714
Parra-Cabrera S, Hernandez-Avila M, Tamayo-y-Orozco J, López-Carrillo L, Meneses-González F (1996) Exercise and reproductive factors as predictors of bone density among osteoporotic women in Mexico City. Calcif Tissue Int 59:89–94
Lissner L, Bengtsson C, Hansson T (1991) Bone mineral content in relation to lactation history in pre- and postmenopausal women. Calcif Tissue Int 48:319–325
Bolzetta F, Veronese N, De Rui M, Berton L, Carraro S, Pizzato S, Girotti G, De Ronch I, Manzato E, Coin A, Sergi G (2014) Duration of breastfeeding as a risk factor for vertebral fractures. Bone 68:41–45. doi:10.1016/j.bone.2014.08.001
Chantry CJ, Auinger P, Byrd RS (2004) Lactation among adolescent mothers and subsequent bone mineral density. Arch Pediatr Adolesc Med 158(7):650–656. doi:10.1001/archpedi.158.7.650
Albright F, Reifenstein EC (1948) Parathyroid glands and metabolic bone disease. Williams & Wilkins, Baltimore
Stride PJ, Patel N, Kingston D (2013) The history of osteoporosis: why do Egyptian mummies have porotic bones? J Royal College Phys Edinburgh 43(3):254–261. doi:10.4997/jrcpe.2013.314
Yamamoto N, Takahashi HE, Tanizawa T, Kawashima T, Endo N (1994) Bone mineral density and bone histomorphometric assessments of postpregnancy osteoporosis: a report of five patients. Calcif Tissue Int 54(1):20–25
Smith R, Athanasou NA, Ostlere SJ, Vipond SE (1995) Pregnancy-associated osteoporosis. Q J Med 88(12):865–878
Khovidhunkit W, Epstein S (1996) Osteoporosis in pregnancy. Osteoporos Int 6(5):345–354
Phillips AJ, Ostlere SJ, Smith R (2000) Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporos Int 11(5):449–454. doi:10.1007/s001980070113
Smith R, Stevenson JC, Winearls CG, Woods CG, Wordsworth BP (1985) Osteoporosis of pregnancy. Lancet 1(8439):1178–1180
Campos-Obando N, Oei L, Hoefsloot LH, Kiewiet RM, Klaver CC, Simon ME, Zillikens MC (2014) Osteoporotic vertebral fractures during pregnancy: be aware of a potential underlying genetic cause. J Clin Endocrinol Metab 99(4):1107–1111. doi:10.1210/jc.2013-3238
Cook FJ, Mumm S, Whyte MP, Wenkert D (2014) Pregnancy-associated osteoporosis with a heterozygous deactivating LDL receptor-related protein 5 (LRP5) mutation and a homozygous methylenetetrahydrofolate reductase (MTHFR) polymorphism. J Bone Miner Res 29(4):922–928. doi:10.1002/jbmr.2095
O’Sullivan SM, Grey AB, Singh R, Reid IR (2006) Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int 17(7):1008–1012. doi:10.1007/s00198-006-0112-3
Khastgir G, Studd JW, King H, Abdalla H, Jones J, Carter G, Alaghband-Zadeh J (1996) Changes in bone density and biochemical markers of bone turnover in pregnancy-associated osteoporosis. Br J Obstet Gynaecol 103(7):716–718
Bonacker J, Janousek M, Krober M (2014) Pregnancy-associated osteoporosis with eight fractures in the vertebral column treated with kyphoplasty and bracing: a case report. Arch Orthop Trauma Surg 134(2):173–179. doi:10.1007/s00402-013-1912-5
Lampropoulou-Adamidou K, Trovas G, Stathopoulos IP, Papaioannou NA (2012) Case report: Teriparatide treatment in a case of severe pregnancy -and lactation- associated osteoporosis. Hormones (Athens, Greece) 11(4):495–500
Stumpf UC, Kurth AA, Windolf J, Fassbender WJ (2007) Pregnancy-associated osteoporosis: an underestimated and underdiagnosed severe disease. A review of two cases in short- and long-term follow-up. Adv Med Sci 52:94–97
Dunne F, Walters B, Marshall T, Heath DA (1993) Pregnancy associated osteoporosis. Clin Endocrinol (Oxf) 39(4):487–490
Lopez LM, Chen M, Mullins S, Curtis KM, Helmerhorst FM (2012) Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database Syst Rev 8:CD009849. doi:10.1002/14651858.CD009849.pub2
Lopez LM, Grimes DA, Schulz KF, Curtis KM, Chen M (2014) Steroidal contraceptives: effect on bone fractures in women. Cochrane Database Syst Rev 6:CD006033. doi:10.1002/14651858.CD006033.pub5
Brandao KL, Mottola MF, Gratton R, Maloni J (2013) Bone status in activity-restricted pregnant women assessed using calcaneal quantitative ultrasound. Biol Res Nurs 15(2):205–212. doi:10.1177/1099800411423807
Dent CE, Friedman M (1965) Pregnancy and idiopathic osteoporosis. Q J Med 34(135):341–357
Nordin BE, Roper A (1955) Post-pregnancy osteoporosis; a syndrome? Lancet 268(6861):431–434
Longstreth PL, Malinak LR, Hill CS Jr (1973) Transient osteoporosis of the hip in pregnancy. Obstet Gynecol 41(4):563–569
Brodell JD, Burns JE Jr, Heiple KG (1989) Transient osteoporosis of the hip of pregnancy. Two cases complicated by pathological fracture. J Bone Joint Surg Am 71(8):1252–1257
Goldman GA, Friedman S, Hod M, Ovadia J (1994) Idiopathic transient osteoporosis of the hip in pregnancy. Int J Gynaecol Obstet 46(3):317–320
Guerra JJ, Steinberg ME (1995) Distinguishing transient osteoporosis from avascular necrosis of the hip. J Bone Joint Surg Am 77(4):616–624
Cano-Marquina A, Tarin JJ, Garcia-Perez MA, Cano A (2014) Transient regional osteoporosis. Maturitas 77(4):324–329. doi:10.1016/j.maturitas.2014.01.012
Lose G, Lindholm P (1986) Transient painful osteoporosis of the hip in pregnancy. Int J Gynaecol Obstet 24(1):13–16
Funk JL, Shoback DM, Genant HK (1995) Transient osteoporosis of the hip in pregnancy: natural history of changes in bone mineral density. Clin Endocrinol (Oxf) 43(3):373–382
Emami MJ, Abdollahpour HR, Kazemi AR, Vosoughi AR (2012) Bilateral subcapital femoral neck fractures secondary to transient osteoporosis during pregnancy: a case report. J Orthop Surg (Hong Kong) 20(2):260–262
Pabinger C, Heu C, Frohner A, Dimai HP (2012) Pregnancy- and lactation-associated transient osteoporosis of both hips in a 32 year old patient with osteogenesis imperfecta. Bone 51(1):142–144. doi:10.1016/j.bone.2012.04.013
Curtiss PH Jr, Kincaid WE (1959) Transitory demineralization of the hip in pregnancy. A report of three cases. J Bone Joint Surg Am 41-A:1327–1333
Anai T, Urata K, Mori A, Miyazaki F, Okamoto S (2013) Transient osteoporosis of the hip in pregnancy associated with generalized low bone mineral density—a case report. Gynecol Obstet Invest 76(2):133–138. doi:10.1159/000351564
Lakhanpal S, Ginsburg WW, Luthra HS, Hunder GG (1987) Transient regional osteoporosis. A study of 56 cases and review of the literature. Ann Intern Med 106(3):444–450
Takatori Y, Kokubo T, Ninomiya S, Nakamura T, Okutsu I, Kamogawa M (1991) Transient osteoporosis of the hip. Magnetic resonance imaging. Clin Orthop Relat Res 271(271):190–194
Aynaci O, Kerimoglu S, Ozturk C, Saracoglu M (2008) Bilateral non-traumatic acetabular and femoral neck fractures due to pregnancy-associated osteoporosis. Arch Orthop Trauma Surg 128(3):313–316. doi:10.1007/s00402-007-0439-z
Bruscas Izu C, Juan S, de la Parra S (2014) Transient osteoporosis of both hips in pregnancy. Reumatol Clin 10(1):58–59. doi:10.1016/j.reuma.2013.01.009
Baki ME, Uygun H, Ari B, Aydin H (2014) Bilateral femoral neck insufficiency fractures in pregnancy. Eklem hastaliklari ve cerrahisi = Joint Dis Relat Surg 25(1):60–62. doi:10.5606/ehc.2014.13
Pallavi P, Padma S, Vanitha Anna Selvi D (2012) Transient osteoporosis of hip and lumbar spine in pregnancy. J Obstet Gynaecol India 62(Suppl 1):8–9. doi:10.1007/s13224-013-0355-9
Ofluoglu O, Ofluoglu D (2008) A case report: pregnancy-induced severe osteoporosis with eight vertebral fractures. Rheumatol Int 29(2):197–201. doi:10.1007/s00296-008-0641-5
Ozturk C, Atamaz FC, Akkurt H, Akkoc Y (2014) Pregnancy-associated osteoporosis presenting severe vertebral fractures. J Obstet Gynaecol Res 40(1):288–292. doi:10.1111/jog.12157
Reid IR, Wattie DJ, Evans MC, Budayr AA (1992) Post-pregnancy osteoporosis associated with hypercalcaemia. Clin Endocrinol (Oxf) 37(3):298–303
Iwamoto J, Sato Y, Uzawa M, Matsumoto H (2012) Five-year follow-up of a woman with pregnancy and lactation-associated osteoporosis and vertebral fractures. Ther Clin Risk Manag 8:195–199. doi:10.2147/tcrm.s30668
Dytfeld J, Horst-Sikorska W (2012) Pregnancy associated osteoporosis—a case report. Ginekol Pol 83(5):377–379
Sarikaya S, Ozdolap S, Acikgoz G, Erdem CZ (2004) Pregnancy-associated osteoporosis with vertebral fractures and scoliosis. Joint Bone Spine 71(1):84–85. doi:10.1016/j.jbspin.2003.05.003
Choe EY, Song JE, Park KH, Seok H, Lee EJ, Lim SK, Rhee Y (2012) Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures. J Bone Miner Metab 30(5):596–601. doi:10.1007/s00774-011-0334-0
Jang JY, Lee JG, Jeong IK, Ahn KJ, Chung HY, Yang HI, Lee SH (2009) A case of post-pregnancy osteoporosis combined with ankylosing spondylitis. Rheumatol Int 29(11):1359–1362. doi:10.1007/s00296-008-0820-4
Ozcelik B, Ozcelik A, Debre M (2009) Postpartum depression co-occurring with lactation-related osteoporosis. Psychosomatics 50(2):155–158. doi:10.1176/appi.psy.50.2.155
Tanriover MD, Oz SG, Sozen T, Kilicarslan A, Guven GS (2009) Pregnancy- and lactation-associated osteoporosis with severe vertebral deformities: can strontium ranelate be a new alternative for the treatment? Spine J 9(4):e20–e24. doi:10.1016/j.spinee.2008.06.451
Zarattini G, Buffoli P, Isabelli G, Marchese M (2014) Pregnancy-associated osteoporosis with seven vertebral compression fractures, a case treated with strontium ranelate. Clin Cases Min Bone Metab 11(2):139–141
Hellmeyer L, Boekhoff J, Hadji P (2010) Treatment with teriparatide in a patient with pregnancy-associated osteoporosis. Gynecol Endocrinol 26(10):725–728. doi:10.3109/09513591003649831
Lee SH, Hong MK, Park SW, Park HM, Kim J, Ahn J (2013) A case of teriparatide on pregnancy-induced osteoporosis. J Bone Metab 20 (2):111–114. doi:10.11005/jbm.2013.20.2.111
Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsenberg D, Gagel RF, Gilsanz V, Guise T, Koka S, McCauley LK, McGowan J, McKee MD, Mohla S, Pendrys DG, Raisz LG, Ruggiero SL, Shafer DM, Shum L, Silverman SL, Van Poznak CH, Watts N, Woo SB, Shane E, American Society for B, Mineral R (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22(10):1479–1491. doi:10.1359/jbmr.0707onj
Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O’Keefe R, Papapoulos S, Howe TS, van der Meulen MC, Weinstein RS, Whyte MP (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29(1):1–23. doi:10.1002/jbmr.1998
Uyanne J, Calhoun CC, Le AD (2014) Antiresorptive drug-related osteonecrosis of the jaw. Dent Clin N Am 58(2):369–384. doi:10.1016/j.cden.2013.12.006
Thompson RN, Armstrong CL, Heyburn G (2014) Bilateral atypical femoral fractures in a patient prescribed denosumab—a case report. Bone 61:44–47. doi:10.1016/j.bone.2013.12.027
Abrahamsen B, Grove EL, Vestergaard P (2014) Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate. Osteoporos Int 25(2):757–762. doi:10.1007/s00198-013-2469-4
Donneau AF, Reginster JY (2014) Cardiovascular safety of strontium ranelate: real-life assessment in clinical practice. Osteoporos Int 25(2):397–398. doi:10.1007/s00198-013-2583-3
Patlas N, Golomb G, Yaffe P, Pinto T, Breuer E, Ornoy A (1999) Transplacental effects of bisphosphonates on fetal skeletal ossification and mineralization in rats. Teratology 60(2):68–73. doi:10.1002/(SICI)1096-9926(199908)60:2<68::AID-TERA10>3.0.CO;2-H
Okazaki A, Matsuzawa T, Takeda M, York RG, Barrow PC, King VC, Bailey GP (1995) Intravenous reproductive and developmental toxicity studies of cimadronate (YM175), a novel bisphosphonate, in rats and rabbits. J Toxicol Sci 20(Suppl 1):1–13
Stathopoulos IP, Liakou CG, Katsalira A, Trovas G, Lyritis GG, Papaioannou NA, Tournis S (2011) The use of bisphosphonates in women prior to or during pregnancy and lactation. Hormones (Athens, Greece) 10(4):280–291
Siminoski K, Fitzgerald AA, Flesch G, Gross MS (2000) Intravenous pamidronate for treatment of reflex sympathetic dystrophy during breast feeding. J Bone Miner Res 15(10):2052–2055. doi:10.1359/jbmr.2000.15.10.2052
Boyce RW, Varela A, Chouinard L, Bussiere JL, Chellman GJ, Ominsky MS, Pyrah IT (2014) Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period. Bone 64:314–325. doi:10.1016/j.bone.2014.04.002
Servier Laboratories (2014) Protos Datasheet. New Zealand Medicines and Medical Devices Safety Authority. http://www.medsafe.govt.nz/profs/datasheet/p/Protossusp.pdf. Accessed March 5, 2015
Kim HW, Song JW, Kwon A, Kim IH (2010) Percutaneous vertebroplasty for pregnancy-associated osteoporotic vertebral compression fractures. J Korean Neurosurg Soc 47(5):399–402. doi:10.3340/jkns.2010.47.5.399
Bayram S, Ozturk C, Sivrioglu K, Aydinli U, Kucukoglu S (2006) Kyphoplasty for pregnancy-associated osteoporotic vertebral fractures. Joint Bone Spine 73(5):564–566. doi:10.1016/j.jbspin.2005.11.015
Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C, Graves S, Staples MP, Murphy B (2009) A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med 361(6):557–568. doi:10.1056/NEJMoa0900429
Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond TH, Edwards R, Gray LA, Stout L, Owen S, Hollingworth W, Ghdoke B, Annesley-Williams DJ, Ralston SH, Jarvik JG (2009) A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med 361(6):569–579. doi:10.1056/NEJMoa0900563
Baroud G, Bohner M (2006) Biomechanical impact of vertebroplasty. Postoperative biomechanics of vertebroplasty. Joint Bone Spine 73(2):144–150. doi:10.1016/j.jbspin.2005.02.004
Baroud G, Nemes J, Heini P, Steffen T (2003) Load shift of the intervertebral disc after a vertebroplasty: a finite-element study. Eur Spine J 12(4):421–426. doi:10.1007/s00586-002-0512-9
Han IH, Chin DK, Kuh SU, Kim KS, Jin BH, Yoon YS, Cho YE (2009) Magnetic resonance imaging findings of subsequent fractures after vertebroplasty. Neurosurgery 64(4):740–744. doi:10.1227/01.neu.0000339120.41053.f1
Truszczynska A, Walczak P, Rapala K (2012) Transient peripartum osteoporosis of the femoral head in first and third pregnancy. J Clin Densitom 15(4):467–471. doi:10.1016/j.jocd.2012.02.010
Acknowledgments
The study received research grant support to CSK from Canadian Institutes of Health Research (grant no. 133413 and no. 84253).
Conflicts of interest
SHR reports having received consultancy fees on behalf of his institution from Novartis and Merck and research grants to his institution from Amgen and Eli Lilly. CSK has received honoraria from Amgen for work unrelated to the topic of this review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kovacs, C.S., Ralston, S.H. Presentation and management of osteoporosis presenting in association with pregnancy or lactation. Osteoporos Int 26, 2223–2241 (2015). https://doi.org/10.1007/s00198-015-3149-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-015-3149-3